Skip to main content

Table 3 Differences in clinical and microbiological characteristics of infectious episodes between the two cohorts

From: Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation

Variable

Cefazolin (n = 73)

Ertapenem (n = 67)

P

Source of infection

 Urinary

62 (85%)

47 (70%)

0.09

 SSI

3 (4%)

6 (9%)

0.5

 Other

8 (11%)

14 (21%)

0.3

Positive blood cultures

10 (14%)

8 (12%)

0.4

Septic shock

2 (3%)

1 (2%)

0.6

Isolated microorganisms

Enterobacteriaceae

47 (64%)

24 (36%)

0.005

  ESBL-producing

10 (21%)a

2 (8%)b

0.01

P. aeruginosa

9 (12%)

9 (14%)

1

  XDR

5 (56%)

2 (22%)

0.2

Enterococcus spp.

24 (33%)

31 (47%)

0.1

  E. faecium

13 (54%)

8 (26%)

0.03

C. difficile colitis

1 (1%)

2 (3%)

1

Candida spp. infection

7 (9%)

3 (5%)

0.1

 CR Enterobacteriaceae

0

0

 
  1. ESBL Extended-spectrum betalactamase-producing, XDR Extensively drug-resistant, CR Carbapenem-resistant
  2. aseven episodes were due to Klebsiella pneumoniae and three to E.coli
  3. ball episodes were due to Klebsiella pneumoniae